Orteronel (TAK-700) in Metastatic or Advanced Non-resectable Granulosa Cell Ovarian Tumors. The Greko II Study.
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Alicia Hurtado, MD
Hospital Universitario Fundación Alcorcón
Principal Investigator - Ana Santaballa, MD
Hospital Universitario La Fe
Principal Investigator - Andrés Redondo, MD
Hospital Universitario La Paz
Principal Investigator - Isabel Bover, MD
Hospital Son Llatzer
Principal Investigator - Jesús García-Donas, MD
Hospital Universitario Madrid Sanchinarro
Study Director - Juan Cueva, MD
COMPLEXO HOSPITALARIO UNIVERSITARIO DE SANTIAGO
Principal Investigator - Laia Garrigos, MD
Hospital del Mar
Principal Investigator - María Jesús Rubio, MD
COMPLEJO HOSPITALARIO REGIONAL REINA SOFÍA
Principal Investigator - Nuria Lainez, MD
Complejo Hospitalario de Navarra
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
9 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Hospital Son Llatzer
Palma de Mallorca, Balearic Islands, Spain
- Complexo Hospitalario Universitario de Santiago
Santiago de Compostela, La Coruña, Spain
- Hospital Universitario Fundación Alcorcón
Alcorcón, Madrid, Spain
- Complejo Hospitalario de Navarra
Pamplona, Navarre, Spain
- Hospital del Mar
Barcelona, Spain
- Complejo Hospitalario Regional Reina Sofía
Córdoba, Spain
- Hospital Universitario la Paz
Madrid, Spain
- Hospital Universitario Madrid Sanchinarro
Madrid, Spain
- Hospital Universitari I Politècnic la Fe
Valencia, Spain
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Jun 2014
- Primary completion
- 11 Jan 2017
- Completion
- 11 Jan 2017
- Last update posted
- 5 Mar 2018
- Registered enrollment
- 10
- Registry id
- NCT02101684
Cross-registrations
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.